Alkem Laboratories Ltd News

Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan

The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

F&O Update: 5 key takeaways from monthly rollovers to July series

Analysts at Axis Securities believe Nifty's strong June rollovers suggest a likely bullish conviction for the July series.

Stocks to Watch, June 3: Alkem Labs, Dhanuka Agritech, Paytm, Canara Bank

Stocks to Watch today, June 3: Infosys, Alkem Labs, Paytm among others in focus; here's why

Alkem launches semaglutide pre-filled syringes in India at ₹350

The company has received DCGI approval for multiple dosage strengths and aims to widen access to semaglutide treatment for diabetes and obesity

Stocks to Watch, June 2: NHPC, Alkem Labs, Wipro, Paytm, Ola Electric

Stocks to Watch, June 2: L&T, Anant Raj, Ola Electric, Paytm, Alkem Labs among shares to remain on investors' and traders' radar today

Alkem Labs up 6% on Q4 beat; early Tolvaptan launch, tax cut cheer Street

In the March quarter, Alkem Laboratories reported a fall in consolidated net profit by 22.7 per cent year-on-year (Y-o-Y) for the fourth quarter (Q4) of the financial year 2025-26 (FY26) to ₹236 crore

Stocks to Watch today: RIL, Lupin, Wipro, Asian Paints, Ireda, Tata Elxsi

Stocks to Watch today, May 29, 2026: Ashok Leyland, Alkem Laboratories, PhysicsWallah, GMR Airports, InterGlobe Aviation, NMDC, and Glenmark Pharma are among the top stocks to remain in focus today

Alkem Q4 profit falls 23% on one-off hit; sees strong FY27 pipeline

The drugmaker said strong domestic branded generics and international business growth helped drive record EBITDA performance in FY26

Q4 results: Ashok Leyland, Alkem Labs, Finolex Cables, 469 more on May 28

Q4FY26 company results: Firms including Bharat Dynamics, Schneider Electric Infra, Deepak Fertilisers & Petrochemicals, and Apar Industries are also to release their January-March earnings today

Sun Pharma, Dr Reddy's Labs, Onesource: Nifty Pharma rallies 3%; details

Among others, Sun Pharma was the top gainer up over 7 per cent, followed by Gland Pharma, Alkem Laboratories, Zydus Lifesciences and Wockhardt up over 2 per cent

Alkem Labs to increase investment to ₹1,036 crore for new unit in Ujjain

Alkem Laboratories Ltd on Thursday announced almost doubling of investment to up to Rs 1,036 crore for its proposed greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh. The board of the directors of the company on April 2 has approved an increase in investment from up to Rs 533 crore to up to Rs 1,036 crore to be made in a phased manner for setting up of manufacturing facility in Ujjain, Alkem Laboratories Ltd said in a regulatory filing. Earlier on March 18, the company had stated that it has received allotment letter from DMIC Vikram Udyogpuri Ltd, for allotment of 30 acres land for setting up of the greenfield formulations manufacturing facility at Ujjain and the company's board had approved an investment of up to Rs 533 crore to be made in a phased manner.

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt

Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations

Stocks to Watch today: HDFC Bank, Ultratech, Vedanta, Nazara Tech, GR Infra

Stocks to Watch today, March 19: HDFC Bank, Ultratech, Vedanta, United Breweries, and Belrise Industries are among the top stocks to watch today

Dividend stocks: Alkem Labs, Irctc, 25 others to remain in spotlight today

Here is the complete list of the stocks trading ex-dividend tomorrow, along with their respective record dates and announced dividend amounts